Since the century or so during which multiple sclerosis has been recognized has brought virtually no progress in elucidating its etiology, the announcement by Rivers, Sprunt & Berry in 1933 of experimental production of demyelinating disease in animals was hailed with hope as well as interest. Whilst their original method involved repeated injections (up to 60 or 70) of brain substance before neurological disturbance appeared, the introduction of adjuvants by Freund and his collaborators in the early 1940s made the production of experimental encephalomyelitis much easier; and when guinea-pigs were shown to be highly susceptible to the experimental disease, laboratories in all parts of the world embarked upon such work. Because Freund's adjuvants (consisting of a light mineral oil, heat killed and dried tubercle or other suitable bacilli, and an emulsifying agent) are known to increase antibody production when injected together with any given antigen, and because of the interval of two to three weeks between injection and onset of neurological disturbance, the condition has come to be looked upon as an experimental allergic encephalomyelitis (E.A.E.) though this has never been proved.
Whilst guinea-pigs and rabbits are most commonly used, monkeys, dogs, sheep and other animals have all been shown to respond and an inadvertent similar experiment has been successfully carried out on man.
My own experiments have been confined to guinea-pigs. A single inoculum into the skin of the dorsum of one foot, consisting of 15 mg of wet normal brain (either human or guinea-pig) with 1 mg of heat killed and dried tubercle bacilli with Bayol F & Arlacel A (a light Esso mineral oil and an emulsifying agent respectively) is made in a volume of 0-2 ml. Within a few days the foot becomes swollen and often ulcerates. At about fourteen to twenty days the animal begins to show neurological disturbance. The hind legs become weak and sometimes rather stiff, and the animal is easily thrown off balance. Nearly always there is a loss of weight of 20-30 g on the day of paresis or on the preceding day. The condition may deteriorate so that the animal comes to drag its hind Jegs whilst its forepart remains quite well; or paralysis may ascend and the animal lie permanently on its side, sometimes showing a continuous tremor or occasional convulsions, especially when handled. Many very sick animals will nevertheless recover, and if paralysis has not been severe they may finally show little more than a persisting slight stiffness of the hind legs. At the height of the illness paralysis of bladder and rectal sphincters is common. About 80-90 % of all guinea-pigs show some degree of neurological disturbance after the injection described above.
Two important questions may be posed: (1) Is so-called experimental 'allergic' encephalomyelitis truly of an allergic nature? (2) If so, what relation does it bear to human diseases such as post-infectious encephalomyelitis and multiple sclerosis?
Whilst the allergic nature of the condition has not been established beyond all doubt, it is generally agreed to be highly probable. The activity of Freund's adjuvants which are known to promote the development of antibodies and tuberculin type sensitivity, the characteristic two to three weeks latent period following injection, the specific efficacy of myelin-containing brain material and the induction of 'tolerance' by injection of brain material into immature animals are the major bases for this belief. However, attempts to demonstrate antibody to brain tissue in the blood during the experimental disease have uniformly failed to establish any correlation between the blood titre and severity of the disease. Animals may be severely ill without antibody being detectable. On the other hand skin sensitivity to the brain material originally injected has been said to parallel the severity of disease. In my own experience such correspondence is, however, only approximate. Practically every animal becomes sensitive to the inoculated heterologous brain, often within forty-eight to seventy-two hours of the injection, while the reaction obtained on skin testing (which is of the delayed tuberculin type) commonly shows little relation to the severity of the disease. Some further difficulties will be considered below.
It is impossible within the limits of this brief presentation to deal with more than a very few isolated aspects of experimental allergic encephalitis.
Pathology: This varies in different species. All show perivascular cuffing with small round cells (lymphocytes) and some authors have also seen plasma cells and occasionally polymorphonuclear leucocytes too. Of more interest is the occurrence of true demyelination. This undoubtedly occurs in monkeys (and in man, as will be seen below), but in guinea-pigs it is usually described as 'uncommon'. In more than 500 animals I have not seen true demyelination. Pale perivascular areas in sections stained for myelin are found on closer examination to be accumulations of cellular infiltrate which push aside neighbouring myelinated fibres producing an illusion of true demyelination; Freund, Stern & Pisani (1947) likewise did not see true demyelination in guinea-pigs. In sum, the changes in experimental allergic encephalomyelitis of the guinea-pig are essentially a meningo-encephalitis and choroiditis, together with widespread perivascular cuffing with lymphocytes, throughout the white matter. These perivascular cuffings may be either limited to the immediate neighbourhood of the vessels being contained within the vascular membrane, or they may spill over into the surrounding nervous parenchyma so that sometimes quite large areas of diffuse infiltration may be found. Even here, however, there is no true demyelination. The roof of the third ventricle is markedly affected. It may be that disintegration of myelin might occur as a sequel around the infiltrated vessels under certain conditions which do not ordinarily obtain in the guinea-pig. It is, for example, conceivable that resorption of 'tissue fluid' from the nervous tissue is impeded by exudate, so that stasis results with local conditions inimical to survival of myelin. In animals, such as the guinea-pig, with a thin cerebral vesicle, dammed-back tissue fluid might escape either to the surface or to the ventricular system whereas in those with thick vesicles this might not be possible and myelin might not survive. Since nervous tissue is devoid of a lymphatic system, clearance of local fluid collections will depend upon ease of diffusion. Put in another way, demyelination may be a sequel of an allergic process in certain animal species, but such demyelination would not itself be directly allergic.
If the disease is indeed an allergic one in which, however, no circulating antibody can be consistently demonstrated, it might be expected that plasma cells would be prominent in the perivascular exudates of the brain lesions. This is not so. Lymphocytes, microglial cells and sometimes polymorphs are present. Alvord & Stevenson (1950) failed to demonstrate microglial cells using Hortega's silver carbonate method. In my own hands, however, the method has given clear and convincing results. There would appear to be three types of lesions so far as microglia is concerned: (1) Perivascular lymphocytic accumulations without microglial cells.
(2) Markedly stimulated and proliferated microglia around a small vein which shows no lymphocytic or plasmacyte infiltration ( Fig. 1). (3) A mixed reaction in which there is a little microglial stimulation near an infiltrated blood vessel.
Stimulation of microglia, so that its normally very delicate and finely branched processes became thickened and coarse, is an early result of change in the 'ground substance' of nervous tissue in which the processes are normally embedded. As a delicate index of disturbance such a change may be present when nerve cells and fibres remain histologically intact (Field 1954 ). In the present context this suggests that some change may take place around the small veins without local lymphocyte or plasma cell accumulation. This is unexpected for a condition of presumed allergic etiology. However, these findings are consonant with those of Vulpe et al. (1960) who, using radioactive iodinated bovine albumin as a tracer substance, found 'increased permeability around blood vessels without any signs of inflammation' and conversely that 'certain blood vessels with signs of inflammatory changes may not show increased permeability'. If the disease is allergic in its pathogenesis then treatments designed to diminish an allergic response might be expected to militate against its development. The effects of sodium salicylate, ACTH, 6-mercaptopurine and irradiation with Xrays have been examined and may be presented very briefly.
(1) X-irradiation: 150 V or 300 V whole body dosage, eighteen hours before inoculation, does not protect against E.A.E. This has been urged by Allegranza (1959) as evidence against the allergic nature of the disease. However, such doses do not abolish the development of skin sensitivity and these experiments do not therefore support his argument. The guinea-pig would appear to be an animal in which irradiation'with X-rays must be of lethal level before immune response is abolished. A full account of this work will appear elsewhere.
(2) Sodium salicylate: has been claimed (Good et al. 1949 ) to protect against E.A.E. if given early enough. Our own experiments suggest that sodium salicylate affords protection only if it is given simultaneously with or soon after the exciting injection, and that it might well act through ACTH discharge.
(3) ACTH: has been confirmed as protecting if given continuously before or from the time of the exciting injection. However, many animals which appear to have been protected clinically show mild histological lesions, so that the effect may represent nothing more than the non-specific familiar anti-inflammatory action of the hormone and not a specific effect on an immune reaction. It should be added that ACTH has not been shown with certainty to depress antibody formation (Scheiffarth 1958). (4) 6-mercaptopurine: has recently been claimed by Hoyer et al. (1960) to offer protection against E.A.E. in rabbits when given intravenously in doses of 12 mg/kg bodyweight per day, though only whilst the injections continued. Independently of these results Dr. Miller and I have found guinea-pigs to tolerate a dose of 6 mg/kg bodyweight when given intramuscularly, but not 10 mg. Beginning with the smaller dose at the time of the exciting injection and continuing-daily throughout, no protection whatsoever was encountered. In fact, the animals appeared to succumb sooner. A full evaluation of these results will be presented elsewhere. Here it may be merely pointed out that they do not afford evidence one way or the other with regard to the allergic nature of experimental encephalomyelitis.
Taking all the evidence together, however, the experimental disease does seem to be allergic in origin. Although certain features remain obscure the position is no worse than in many other conditions widely accepted as allergic.
What is the relation of this experimental disease to human conditions? In the first place it now seems clear that brain tissue when repeatedly injected into humans can produce an E.A.E. The cases published by Uchimura & Shiraki (1957) of perivenous and ultimately confluent demyelinating lesions following Pasteur treatment of suspected rabic infection are now well known. More recently a case presenting even closer analogies with E.A.E. has been published by Jellinger & Seitelberger (1958) . At the age of 47 a man began to suffer from progressive left-sided parkinsonism which could not be controlled by the usual medicaments. He was, therefore, given a course of seven injections of lyophylized calf brain over the space of eighteen months. For good measure some placenta was also added. Great care was taken to ensure the sterility of the inocula but twenty-two days after his last injection, when the patient was 51 years of age, he developed a rapidly progressing neurological illness and died in coma. Examination showed an acute demyelinating encephalomyelitis with confluence of lesions around the angles of the lateral ventricles.
The central problem remains to establish the relationship of such findings to human M.S., with its dramatic onset or its slow insidious progression with absence of any obvious exciting feature. It seems a far cry from the experimental animal with its severe local reaction following the administration of an inoculum containing adjuvants to the ordinary human case. However, many years ago Burky (1934) found that staphylococcal toxins might act as adjuvants in aiding the production of antibodies and later Cavelti (1947) found that killed streptococci could act as adjuvants. Such observations might be relevant in the genesis of a human auto-immune disease.
If M.S. is in truth essentially an auto-immune disease and not due to a virus or an intoxication, E.A.E. of animals may be a useful model for the disease process in humans. Consideration of the different pictures obtained in various species suggests that some allergic alteration in the bio-chemical characters of the-small vein walls might be the essential change and the prominent demyelination upon which so much attention has been lavished a secondary occurrence.
Professor Lumsden challenged the statement that allergic encephalitis in the guinea-pig was essentially a choriomeningitis. He had never claimed that this was a 'demyelinating' process in any strict sense in the guinea-pig but he thought all workers would agree that this form of encephalitis selected that part of the guinea-pig brain which was the equivalent of the centrum ovale in man, constantly and symmetrically, and also the white matter of the spinal cord. Grey matter and membranes were less constantly and selectively involved. The lesions appeared as a profound disturbance in the vessel walls, extending secondarilyas far as one could judgeinto the parenchyma of the brain; but this occurred above all in the central white matter symmetrically all round the ventricular system. It was true, however, that there was a spill-over of inflammatory cells into the pia arachnoid in places, quite markedly so at times. Dr Field agreed with Professor Lumsden that the major lesions in guinea-pigs were to be found in the white matter. Mild cases, however, commonly showed little more than patchy meningitis and infiltration 6f the tela choroidea. The point was that the early lesions were associated with the small blood vessels as a choriomeningitis and a vasculitis of the white matter. Demyelination was not a feature of the disease in the guinea-pig though in certain other animals this did occur.
Dr J Colover (London) did not think that to obtain severe reactions it was necessary to use pristine or intact brain tissue. American workers had shownand he had confirmedthat certain central nervous system extracts were, on a weight-for-weight basis, more active than dehydrated brain tissue. From this fact it did not seem that purification of these substances necessarily eliminated their activity.
His experience of the cytology of these lesions had been similar to that of Dr Field. He had examined many lesions but had seen no plasma cells. At the Bethesda Symposium on allergic encephalitis, in 1957, he had discussed this point with others, who had told him that plasma cells appeared only in late survivors of the experiments. Had Dr Field run his experiments over thirty days?
He had seen necrosis in the brains of guinea-pigs with allergic encephalitis only when he had used unheated brain tissue. With heated brain tissue he had never found necrotic lesions although he did see granulomatous lesions.
In patients with D.S. a matter of some importance was the significance of the globulin content of the C.S.F. The y globulin seemed to be variable. Dr Colover exhibited two protein profiles, one from a patient with only a few weeks' history and a very high y globulin and the other from a patient with a long history and a y globulin only a little raised. The explanation of such results might help to elucidate the nature of this disease. Dr Field, replying to Dr Colover, said that in his experiments abundant polymorphs had been present in lesions when the animal had been for some time in coma or had been found dead (when the ante-mortem state was not known). He had not seen abundant plasma cells even after thirty days. He thought there was always some loss in preparation of encephalitogenic materials with high specific activity.
Professor Lumsden had referred to Steffen's demonstration of antibody to brain in the serum of patients with D.S. Dr Ridley and Dr Field had repeated this work with negative results and had been unable to demonstrate antibody capable of sticking to either normal or disseminated sclerotic brain substance in the spinal fluid of cases of this disease. The biological nature of the y globulin present in excess in C.S.F. was uncertain but such globulin could conceivably be derived from the breakdown of nervous tissue.
Professor G Payling Wright said that Dr Field had stated that in one animal he had injected the antigen and adjuvant into the hind foot, and from his results it seemed that the subsequent lesions affected chiefly the hind and not the fore limbs. Could a parallel be drawn with neurotropic viruses and toxins, for with them the first signs of action appeared in the injected limb, presumably because of their centripetal movement along large regional nerve trunks? In short, could Dr Field modify the site of his reactions in the central nervous system by altering the locus of his injections? Dr Field said that he had not studied any possible relationship between the site of inoculation of encephalitogenic mixture and the localization of lesions.
